We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$114M
AUM Growth
-$23.6M
Cap. Flow
-$8.89M
Cap. Flow %
-7.77%
Top 10 Hldgs %
48.95%
Holding
74
New
18
Increased
7
Reduced
11
Closed
24

Top Buys

Rank Stock Value
1
HNT
HEALTH NET INC
HNT
+$3.16M
2
MRK icon
Merck
MRK
+$2.39M
3
SLTM
SOLTA MED INC (DE)
SLTM
+$2.02M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.95M
5
ANIP icon
ANI Pharmaceuticals
ANIP
+$1.3M

Top Sells

Rank Stock Value
1
ARAY icon
Accuray
ARAY
+$3.89M
2
CAH icon
Cardinal Health
CAH
+$3.3M
3
TECH icon
Bio-Techne
TECH
+$2.76M
4
OFIX icon
Orthofix Medical
OFIX
+$1.92M
5
HUM icon
Humana
HUM
+$1.84M

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.65%
2 Healthcare 43.35%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARAY icon
51
Accuray
ARAY
$31.3M
– –
-677,749
Closed -$3.89M
AZN icon
52
CALL
AstraZeneca
AZN
$255B
– –
-25,000
Closed -$1.18M
BSX icon
53
CALL
Boston Scientific
BSX
$67.6B
– –
-100,000
Closed -$927K
CAH icon
54
Cardinal Health
CAH
$54.7B
– –
-69,886
Closed -$3.3M
GSK icon
55
CALL
GSK
GSK
$101B
– –
-20,000
Closed -$1.25M
IBB icon
56
PUT
iShares Biotechnology ETF
IBB
$10.8B
– –
-75,000
Closed -$4.35M
OFIX icon
57
Orthofix Medical
OFIX
$392M
– –
-71,200
Closed -$1.92M
SNY icon
58
CALL
Sanofi
SNY
$107B
– –
-25,000
Closed -$1.29M
TECH icon
59
Bio-Techne
TECH
$11.4B
– –
-160,000
Closed -$2.76M
VNDA icon
60
CALL
Vanda Pharmaceuticals
VNDA
$329M
– –
-75,000
Closed -$606K
NUVA
61
DELISTED
NuVasive, Inc.
NUVA
– –
-65,588
Closed -$1.63M
SPPI
62
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-100,000
Closed -$746K
SPPI
63
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
– –
-80,315
Closed -$599K
ARNA
64
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-5,000
Closed -$385K
ALXN
65
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-25,000
Closed -$2.31M
WCG
66
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-30,000
Closed -$1.67M
MDCO
67
PUT
DELISTED
Medicines Co
MDCO
– –
-50,000
Closed -$1.54M
ESRX
68
CALL
DELISTED
Express Scripts Holding Company
ESRX
– –
-10,000
Closed -$617K
STJ
69
DELISTED
St Jude Medical
STJ
– –
-31,349
Closed -$1.43M
AUXL
70
CALL
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
– –
-150,000
Closed -$2.5M
FRX
71
CALL
DELISTED
FOREST LABORATORIES INC
FRX
– –
-50,000
Closed -$2.05M
AH
72
DELISTED
Accretive Health
AH
– –
-49,100
Closed -$531K
CRTX
73
DELISTED
CORNERSTONE THERAPEUTICS INC
CRTX
– –
-108,168
Closed -$975K
HMA
74
DELISTED
HEALTH MGMT ASSOC INC CL-A
HMA
– –
-100,000
Closed -$1.57M
1 2
3

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Healthcare Value Capital held 74 positions worth $114M, down 17% from $138M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Healthcare Value Capital withdrew a net $8.89M in Q3 2013, closing 24 positions and reducing 11 holdings. Its most notable exit was Accuray, an estimated $3.89M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 60% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Healthcare Value Capital opened a new position in HEALTH NET INC worth $3.17M.

  • Healthcare Value Capital's largest Q3 2013 buy was HEALTH NET INC: 100,000 shares worth $3.17M.
  • Healthcare Value Capital added most to Merck in Q3 2013, an estimated $2.39M increase.
  • Healthcare Value Capital's biggest Q3 2013 reduction was Humana, cutting an estimated $1.84M.
  • Healthcare Value Capital fully exited Accuray in Q3 2013, selling an estimated $3.89M.
  • Healthcare Value Capital's ten largest holdings make up 49% of its $114M portfolio in Q3 2013.
  • Healthcare Value Capital opened 18 new positions and closed 24 in Q3 2013.
  • Healthcare Value Capital's portfolio value fell 17% quarter-over-quarter to $114M.

Based on Healthcare Value Capital's 13F filing for Q3 2013, filed 5 Nov 2013.